FENC Fennec Pharmaceuticals Inc. Total Debt to Capital

Fennec Pharmaceuticals (FENC) leads in pediatric hearing protection during chemotherapy thanks to the approved Pedmark, which benefits from patent protection and orphan drug status. This chart for the separate_debt_total_eq metric is fixed at 0.00. The business is scaling through the high profitability of active substance synthesis, while the absence of direct competitors guarantees the company total control over its market niche and high margins.

The total debt-to-equity ratio measures the proportion of borrowed funds in the financing structure relative to equity. Investors utilize this ratio to assess the degree of financial leverage and bankruptcy risks. By analyzing the ratio of total financial debt to equity, one can observe the dynamics of the credit load. This is critical for Fennec Pharmaceuticals (FENC), as synthesis automation requires investment and costly clinical trials create a need for liquidity. An optimal balance ensures the sustainability of biopharmaceutical developments.